Back to top
more

Clover Health Investments (CLOV)

(Real Time Quote from BATS)

$0.66 USD

0.66
2,675,611

-0.02 (-2.94%)

Updated Apr 29, 2024 02:19 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 252)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CLOV

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Clover Health Investments, Corp falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 243 335 615 28 0
Receivables 81 94 62 0 0
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 104 196 75 0 0
Total Current Assets 428 625 753 28 0
Net Property & Equipment 5 6 2 0 0
Investments & Advances 121 138 176 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 3 20 4 0 0
Deposits & Other Assets 10 16 10 828 0
Total Assets 571 809 951 856 0
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 37 32 28 0 0
Current Portion Long-Term Debt 1 0 0 1 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 21 24 15 5 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 200 382 326 28 0
Total Current Liabilities 261 441 373 34 0
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 29 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 20 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 20 16 14 789 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 284 461 411 851 0
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,461 2,319 2,154 12 0
Retained Earnings -2,160 -1,956 -1,617 -7 0
Other Equity -2 -9 2 0 0
Treasury Stock 13 7 0 0 0
Total Shareholder's Equity 286 348 539 5 0
Total Liabilities & Shareholder's Equity 571 809 951 856 0
Total Common Equity 286 348 539 5 0
Shares Outstanding 489.00 478.30 470.80 24.60 NA
Book Value Per Share 0.59 0.73 1.15 0.20 0.00

Fiscal Year End for Clover Health Investments, Corp falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 243 517 521 417
Receivables NA 81 131 130 135
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 104 268 479 723
Total Current Assets NA 428 916 1,129 1,274
Net Property & Equipment NA 5 5 5 5
Investments & Advances NA 121 102 86 136
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 3 19 19 20
Deposits & Other Assets NA 10 15 15 15
Total Assets NA 571 1,060 1,258 1,454
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 37 35 40 47
Current Portion Long-Term Debt NA 1 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 21 24 20 30
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 200 657 846 1,031
Total Current Liabilities NA 261 719 908 1,110
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 16 16 16
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 284 738 927 1,130
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 2,461 2,428 2,395 2,359
Retained Earnings NA -2,160 -2,089 -2,048 -2,019
Other Equity NA -2 -5 -7 -7
Treasury Stock NA 13 12 10 9
Total Shareholder's Equity NA 286 322 331 323
Total Liabilities & Shareholder's Equity NA 571 1,060 1,258 1,454
Total Common Equity 0 286 322 331 323
Shares Outstanding 495.20 489.00 487.20 483.60 482.60
Book Value Per Share 0.00 0.59 0.66 0.68 0.67